Immuneering (IMRX) Other financing activities (2020 - 2025)
Immuneering (IMRX) recorded quarterly Other financing activities of $587355.0 in Q4 2025, up 193.68% quarter-over-quarter from $200000.0 in Q3 2025, and up 1332.99% on a YoY basis from $40988.0 in Q4 2024.
Immuneering (IMRX) Other financing activities (2020 - 2025) Analysis & Trends
Immuneering's Other financing activities history runs 4 years deep, the most recent figure standing at $587355.0 for Q4 2025.
- In Q4 2025, Other financing activities rose 1332.99% year-over-year to $587355.0; the TTM figure through Dec 2025 stood at $914717.0 (up 618.2% YoY), while the FY2025 annual figure was $3.7 million, up 8991.11% from the prior year.
- Other financing activities was $587355.0 for Q4 2025 at Immuneering, up from $200000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $587355.0 in Q4 2025 to a low of $40988.0 in Q4 2024.
- Historically, Other financing activities has averaged $199348.7 across 3 years, with a median of $143187.0 in 2024.
- Biggest YoY gain for Other financing activities was 1332.99% in 2025; the steepest drop was 131.55% in 2025.
- A 3-year view of Other financing activities shows it stood at $226775.0 in 2022, then sank by 81.93% to $40988.0 in 2024, then soared by 1332.99% to $587355.0 in 2025.
- The last three Other financing activities figures came in at $587355.0 (Q4 2025), $200000.0 (Q3 2025), and $40988.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 587,355.00 |
| Dec 31, 2025 | 587,355.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Dec 31, 2024 | 40,988.00 |
| Dec 31, 2024 | 40,988.00 |
| Sep 30, 2024 | 86,374.00 |
| Sep 30, 2024 | 86,374.00 |
| Dec 31, 2022 | 226,775.00 |
| Dec 31, 2022 | 226,775.00 |
| Sep 30, 2022 | 54,600.00 |
| Sep 30, 2022 | 54,600.00 |
| Dec 31, 2020 | 216,019.00 |
| Dec 31, 2020 | 216,019.00 |